Brightspring Health Services Inc (BTSG)

Brightspring Health Services Inc. witnessed recent insider trading activity involving officer Scott A. Greenwell, who executed a sale of 15,099 shares valued at approximately $874,383. This transaction follows a period where the stock price declined 10.4% over ninety days, despite a positive earnings report last July showing a 21.6% beat on expectations.
Ticker: BTSG Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Brightspring Health Services Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Greenwell Scott A. President, PharMerica Officer
Transaction date
Sale
Price
40.91
Quantity 53,170 +2.2%
Value US$49,256
Greenwell Scott A. Officer Officer
Transaction date
Proposed sale
Price
29.09
Quantity 57,866
Value US$2,240,325
1.5
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
499.19
Quantity 72,847 -18.5%
Value US$3,005,620
2.4
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
58.75
Quantity 35,000 -12.3%
Value US$2,056,250
2.4
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
58.75
Quantity 35,000 -12.3%
Value US$2,056,250
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
58.75
Quantity 130,000 -100.0%
Value US$7,637,500
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
58.75
Quantity 130,000 -9.8%
Value US$7,637,500
1.4
Barnes Robert Allen Former Officer Officer
Transaction date
Proposed sale
Price
60.27
Quantity 62,608
Value US$3,773,232
1.4
Barnes Robert Allen Former Officer Officer
Transaction date
Proposed sale
Price
59.95
Quantity 9,201
Value US$551,567
1.5
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
41.15
Quantity 30,000 -21.3%
Value US$1,234,500
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
41.15
Quantity 220,000 -17.7%
Value US$9,053,000
2.4
Phipps Jennifer A Chief Financial Officer Officer
Transaction date
Sale
Price
41.15
Quantity 35,000 -15.1%
Value US$1,440,250
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
28.78
Quantity 235,000 -17.2%
Value US$6,763,770
1.5
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
28.78
Quantity 20,000 -13.2%
Value US$575,640
1.4
McMaude Michael A Former Officer Officer
Transaction date
Proposed sale
Price
22.40
Quantity 16,168
Value US$362,241
1.4
Barnes Robert Allen President, Community Living Officer
Transaction date
Sale
Price
21.75
Quantity 30,730 -43.9%
Value US$668,378
1.5
Nalley Lisa A See Remarks Officer
Transaction date
Sale
Price
21.75
Quantity 14,415 -9.9%
Value US$313,526
1.4
McMaude Michael A See Remarks Officer
Transaction date
Sale
Price
21.75
Quantity 119,298 -36.5%
Value US$2,594,732
2.4
Phipps Jennifer A Chief Accounting Officer Officer
Transaction date
Sale
Price
21.75
Quantity 15,616 -6.4%
Value US$339,648
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Sale
Price
21.75
Quantity 531,840 -31.0%
Value US$11,567,520
Walgreen Co. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
22.15
Quantity 12,000,000
Value US$265,800,000
2.9
Walgreens Boots Alliance, Inc. Large shareholder
Transaction date
Sale
Price
129,330,577.74
Quantity 11,619,998 -33.3%
Value US$1,502,821,054,677,644
2.4
KKR Group Partnership L.P. Large shareholder
Transaction date
Purchase
Price
11.13
Quantity 11,619,998 +14.3%
Value US$129,330,578
2.2
DAmbrosio Matthew Non-Executive Director
Transaction date
Purchase
Price
11.46
Quantity 1,000 +inf%
Value US$11,461
3.3
Yowler Jennifer President, PharMerica Officer
Transaction date
Purchase
Price
8.21
Quantity 3,000 +5.2%
Value US$24,630
3.6
Mattingly James F Jr See Remarks Officer
Transaction date
Purchase
Price
8.26
Quantity 6,080 +4.7%
Value US$50,221
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.09
Quantity 18,400 +5.2%
Value US$148,856
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.09
Quantity 18,400 +1.8%
Value US$148,856
2.5
ROUSSEAU JON B See Remarks Executive Director
Transaction date
Purchase
Price
8.12
Quantity 37,405 +1921.2%
Value US$303,729
3.6
Mattingly James F Jr See Remarks Officer
Transaction date
Purchase
Price
8.18
Quantity 12,280 +10.5%
Value US$100,450
2.4
Phipps Jennifer A Chief Accounting Officer Officer
Transaction date
Purchase
Price
8.14
Quantity 12,300 +8.0%
Value US$100,122
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-16 2026-09-14 S Sale

President, PharMerica

Officer
53,170 +2.2%
40.91
US$49,256
53,170 +2.2% 40.91 US$49,256
2026-09-14 2026-09-14 PrS Proposed sale

Officer

Officer
57,866
29.09
US$2,240,325
57,866 29.09 US$2,240,325
2026-06-05 2026-06-05 S Sale

See Remarks

Officer
72,847 -18.5%
499.19
US$3,005,620
72,847 -18.5% 499.19 US$3,005,620
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale

Chief Financial Officer

Officer
35,000 -12.3%
58.75
US$2,056,250
35,000 -12.3% 58.75 US$2,056,250
2026-06-05 2026-06-05 S Sale

Chief Financial Officer

Officer
35,000 -12.3%
58.75
US$2,056,250
35,000 -12.3% 58.75 US$2,056,250
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale Large shareholder
14,669,771 -35.1%
58.45
US$857,492,124
14,669,771 -35.1% 58.45 US$857,492,124
2026-06-05 2026-06-05 S Sale

See Remarks

Executive Director
130,000 -100.0%
58.75
US$7,637,500
130,000 -100.0% 58.75 US$7,637,500
2026-06-05 2026-06-05 S Sale

See Remarks

Executive Director
130,000 -9.8%
58.75
US$7,637,500
130,000 -9.8% 58.75 US$7,637,500
2026-06-03 2026-06-03 PrS Proposed sale

Former Officer

Officer
62,608
60.27
US$3,773,232
62,608 60.27 US$3,773,232
2026-06-02 2026-06-02 PrS Proposed sale

Former Officer

Officer
9,201
59.95
US$551,567
9,201 59.95 US$551,567
2026-03-06 2026-03-04 S Sale

See Remarks

Officer
30,000 -21.3%
41.15
US$1,234,500
30,000 -21.3% 41.15 US$1,234,500
2026-03-06 2026-03-04 S Sale

See Remarks

Executive Director
220,000 -17.7%
41.15
US$9,053,000
220,000 -17.7% 41.15 US$9,053,000
2026-03-06 2026-03-04 S Sale

Chief Financial Officer

Officer
35,000 -15.1%
41.15
US$1,440,250
35,000 -15.1% 41.15 US$1,440,250
2026-03-04 2026-03-04 S Sale Large shareholder
19,715,000 -31.8%
40.96
US$807,546,115
19,715,000 -31.8% 40.96 US$807,546,115
2026-03-04 2026-03-04 S Sale Large shareholder
19,715,000 -31.8%
40.96
US$807,546,115
19,715,000 -31.8% 40.96 US$807,546,115
2025-10-22 2025-10-22 S Sale Large shareholder
14,745,000 -19.1%
28.78
US$424,390,590
14,745,000 -19.1% 28.78 US$424,390,590
2025-10-22 2025-10-22 S Sale Large shareholder
14,745,000 -19.1%
28.78
US$424,390,590
14,745,000 -19.1% 28.78 US$424,390,590
2025-10-22 2025-10-22 S Sale

See Remarks

Executive Director
235,000 -17.2%
28.78
US$6,763,770
235,000 -17.2% 28.78 US$6,763,770
2025-10-22 2025-10-22 S Sale

See Remarks

Officer
20,000 -13.2%
28.78
US$575,640
20,000 -13.2% 28.78 US$575,640
2025-08-14 2025-08-14 PrS Proposed sale

Former Officer

Officer
16,168
22.40
US$362,241
16,168 22.40 US$362,241
2025-06-26 2025-06-24 S Sale Large shareholder
2,100,000 -2.7%
21.15
US$44,418,990
2,100,000 -2.7% 21.15 US$44,418,990
2025-06-26 2025-06-24 S Sale Large shareholder
2,100,000 -2.7%
21.15
US$44,418,990
2,100,000 -2.7% 21.15 US$44,418,990
2025-06-16 2025-06-12 S Sale Large shareholder
13,288,101 -14.3%
21.15
US$281,068,584
13,288,101 -14.3% 21.15 US$281,068,584
2025-06-16 2025-06-12 S Sale Large shareholder
13,288,101 -14.3%
21.15
US$281,068,584
13,288,101 -14.3% 21.15 US$281,068,584
2025-06-13 2025-06-12 S Sale

President, Community Living

Officer
30,730 -43.9%
21.75
US$668,378
30,730 -43.9% 21.75 US$668,378
2025-06-13 2025-06-12 S Sale

See Remarks

Officer
14,415 -9.9%
21.75
US$313,526
14,415 -9.9% 21.75 US$313,526
2025-06-13 2025-06-12 S Sale

See Remarks

Officer
119,298 -36.5%
21.75
US$2,594,732
119,298 -36.5% 21.75 US$2,594,732
2025-06-13 2025-06-12 S Sale

Chief Accounting Officer

Officer
15,616 -6.4%
21.75
US$339,648
15,616 -6.4% 21.75 US$339,648
2025-06-13 2025-06-12 S Sale

See Remarks

Executive Director
531,840 -31.0%
21.75
US$11,567,520
531,840 -31.0% 21.75 US$11,567,520
2025-02-20 2025-02-18 S Sale

Former 10% owner

12,000,000 -51.6%
21.16
US$253,920,000
12,000,000 -51.6% 21.16 US$253,920,000
2025-02-18 2025-02-18 PrS Proposed sale

10% Stockholder

Large shareholder
12,000,000
22.15
US$265,800,000
12,000,000 22.15 US$265,800,000
2024-09-13 2024-09-11 S Sale Large shareholder
11,619,998 -33.3%
129,330,577.74
US$1,502,821,054,677,644
11,619,998 -33.3% 129,330,577.74 US$1,502,821,054,677,644
2024-09-13 2024-09-11 B Purchase Large shareholder
11,619,998 +14.3%
11.13
US$129,330,578
11,619,998 +14.3% 11.13 US$129,330,578
2024-09-13 2024-09-11 B Purchase Large shareholder
11,619,998 +14.3%
11.13
US$129,330,578
11,619,998 +14.3% 11.13 US$129,330,578
2024-05-21 2024-05-20 B Purchase Non-Executive Director
1,000 +inf%
11.46
US$11,461
1,000 +inf% 11.46 US$11,461
2024-03-18 2024-03-15 B Purchase

President, PharMerica

Officer
3,000 +5.2%
8.21
US$24,630
3,000 +5.2% 8.21 US$24,630
2024-03-18 2024-03-15 B Purchase

See Remarks

Officer
6,080 +4.7%
8.26
US$50,221
6,080 +4.7% 8.26 US$50,221
2024-03-18 2024-03-15 B Purchase

See Remarks

Executive Director
18,400 +5.2%
8.09
US$148,856
18,400 +5.2% 8.09 US$148,856
2024-03-18 2024-03-15 B Purchase

See Remarks

Executive Director
18,400 +1.8%
8.09
US$148,856
18,400 +1.8% 8.09 US$148,856
2024-03-15 2024-03-14 B Purchase

See Remarks

Executive Director
37,405 +1921.2%
8.12
US$303,729
37,405 +1921.2% 8.12 US$303,729
2024-03-15 2024-03-14 B Purchase

See Remarks

Officer
12,280 +10.5%
8.18
US$100,450
12,280 +10.5% 8.18 US$100,450
2024-03-15 2024-03-14 B Purchase

Chief Accounting Officer

Officer
12,300 +8.0%
8.14
US$100,122
12,300 +8.0% 8.14 US$100,122